Oxabolone cipionate
Appearance
Clinical data | |
---|---|
Trade names | Steranabol Depo, Steranabol Ritardo |
Other names | FI-5852 |
Routes of administration | Intramuscular injection[1] |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.013.647 |
Chemical and physical data | |
Formula | C26H38O4 |
Molar mass | 414.578 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Oxabolone cipionate (INN, JAN) (brand names Steranabol Depo, Steranabol Ritardo; former developmental code name FI-5852), or oxabolone cypionate, also known as 4-hydroxy-19-nortestosterone 17β-cypionate or estr-4-en-4,17β-diol-3-one 17β-cypionate, is synthetic, injected anabolic-androgenic steroid (AAS) and derivative of 19-nortestosterone (nandrolone) that has been marketed in Europe.[2][3][1] It is the C17β cypionate ester and a prodrug of oxabolone (4-hydroxy-19-nortestosterone).[2][3]
See also
- 4-Hydroxytestosterone
- Clostebol (4-chlorotestosterone)
- Formestane (4-hydroxyandrostenedione)
- Norclostebol (4-chloro-19-nortestosterone)
References
- ^ a b H.-L. Krüskemper (22 October 2013). Anabolic Steroids. Elsevier. pp. 203–. ISBN 978-1-4832-6504-9.
- ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1–. ISBN 978-1-4757-2085-3.
- ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 764–765. ISBN 978-3-88763-075-1.